OncoTargets and Therapy (May 2020)

MiR-486-5p Act as a Biomarker in Endometrial Carcinoma: Promotes Cell Proliferation, Migration, Invasion by Targeting MARK1

  • Zheng X,
  • Xu K,
  • Zhu L,
  • Mao M,
  • Zhang F,
  • Cui L

Journal volume & issue
Vol. Volume 13
pp. 4843 – 4853

Abstract

Read online

Xiaojiao Zheng, Kejun Xu, Linyan Zhu, Meiya Mao, Fubin Zhang, Lining Cui Department of Obstetrics and Gynecology, Ningbo First Hospital, Ningbo, Zhejiang 315035, People’s Republic of ChinaCorrespondence: Lining CuiDepartment of Obstetrics and Gynecology, Ningbo First Hospital, 59 Liuting Street, Haishu District, Ningbo, Zhejiang 315035, People’s Republic of ChinaEmail [email protected]: miRNA expression acts as a potential biomarker in many diseases including endometrial carcinoma (EC). miR-486-5p dysregulation is observed in several tumor types, but the roles of miR-486-5p in EC are hardly ever studied.Objective: This study aimed to analyze the expression profile of miR-486-5p in tumor tissues and serum samples of patients with EC and explore the target prediction, function analysis and validation in immortal cell lines.Patients and Methods: A total of 42 freshly paired EC tissues, the corresponding adjacent non-neoplastic tissues and serum samples were also collected from patients with EC, and 42 matched normal serum samples were included as control group. The level of miR-486-5p expression was tested by quantitative real-time polymerase chain reaction (qRT-PCR). Cell proliferation was determined by colony formation assay and CCK-8 assay. Furthermore, functional evaluation of miR-486-5p on migration was performed by wound-healing assay and invasion was estimated by transwell invasion assay. qRT-PCR, luciferase reporter assay and Western blotting (WB) were performed to verify the targeting of MARK1 by miR-486-5p.Results: miR-486-5p was significantly up-regulated in EC tissues and serum samples, promoting the proliferation, migration and invasive activities of EC cells by targeting MARK1.Conclusion: These data indicated miR-486-5p as a novel molecular biomarker for diagnosing and treating EC, and MARK1 might act as a critical and functional target of miR-486-5p with the implications on cell proliferation, migration and invasiveness of EC tumor cells.Keywords: endometrial carcinoma, miR-486-5p, MARK1, proliferation, migration, invasion

Keywords